69 result(s) for 'Multiplex'
61 - 69 of 69 results for 'Multiplex'
Sort by
Show
Dean joined Leica Biosystems in 2016 and is a senior scientist in the R&D team in Melbourne, working on advanced staining projects. He graduated from Monash University where he pursued a PhD, with the department of Immunology and Pathology. During this time, he investigated the role of T cell lineages in mediating inflammatory retinal disorders. He assessed cellular interactions using fluorescent multiplex IHC with confocal microscopy imaging of retinal wholemounts.
Live and recorded scientific educational resources presented by industry thought leaders...
LBS Life Sciences Content
Life Sciences Solutions
Educational Resources
Articles
Webinars
...
Tom is the Manager of Product Technology & Strategy at Leica Biosystems. He is currently leading Spatial Profiling new product development focusing on making clinical impacts. He came to LBS three years ago as a Principal Scientist supporting multiplex assay expansion strategies. Tom has been in the IVD industry for 15+ years; he holds a B.S. in Chemistry from Haverford College, a Ph.D. in Chemistry from Duke University and completed postdoctoral studies in Chemical Engineering at the Massachusetts Institute of Technology.
Charlotte Gray is an Applications Consultant at Leica Biosystems in the UK, specializing in advanced staining with a particular interest in life science applications. Charlotte has a decade of experience after graduating from the University of Nottingham with a BSc (Hons) Medical Science degree. She started her career as an HCPC registered Biomedical Scientist in the NHS working in Histology and was the lead for her trust’s involvement in the 100,000 Genomes Project. Charlotte then worked at the University of Birmingham as Tissue Services Manager and was responsible for managing a research Histology lab, implementing multiplex IHC/ISH, and contributing to digital analysis. During her time at the university, she completed her MSc in Genomic Medicine degree. Charlotte has interes...
Stephanie is a Lecturer in Precision Medicine at the Patrick G. Johnson Centre for Cancer Research, Queen’s University Belfast. She has a breath of experience in the application and validation of translational cancer research methodologies using molecular pathology techniques (immunohistochemistry, in situ hybridisation, multiplex immunofluorescence) and statistics. Her research focuses on predictive biomarker studies and understanding confounding variables that influence the prediction of poor prognosis subgroups in cancer research including reproducible study design, choice of molecular test and assessment criteria.
Gourab Chatterjee joined Ultivue over 5 years ago and played integral roles towards developing the foundational InSituPlex technology and building the FixVUE. FlexVUE and UVUE product portfolios. He is currently leading the research and development efforts at Ultivue towards expanding the applications of ISP technology towards fast and accurate multiplexed biomarker detection across diverse areas of interest in spatial phenomics.
Gourab graduated with B. Tech. and M. Tech. degrees in Biotechnology and Biochemical Engineering from the Indian Institute of Technology Kharagpur, India. Following that, he pursued his Ph.D. in Bioengineering from University of Washington Seattle with Georg Seelig, where he developed novel nucleic acid-based nanoscale computational devices for in-vitr...
Robyn Broad completed her undergraduate degree in Biochemistry at the University of Manchester, UK in 2014. During her undergraduate degree, she had the opportunity of undertaking a placement year, which she completed at MedImmune, Cambridge UK. During her time at MedImmune, Robyn worked in both the phage display team and histology group, producing, and identifying IHC compatible antibodies for targets where commercial antibodies were not currently available. Following completion of her undergraduate degree, Robyn received her MSc in Cancer Research and Molecular Biomedicine again from the University of Manchester and received her PhD from the School of Medicine at the University of Leeds in 2019, where she investigated the role of cancer-associated fibroblasts on chemoresistan...
Helping academic researchers achieve more: BOND RXm – Fully Automated Advanced Staining
Enjoy more time for academic research with BOND RXm fully automating your IHC, ISH and emerging tests. The unmatched protocol flexibility and fully open reagents mean you retain complete control of your staining. The three independent slide trays also ensure slides run to your timetable.